Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions



Similar documents
Diabetes: When To Treat With Insulin and Treatment Goals

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians

INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT

Harmony Clinical Trial Medical Media Factsheet

How To Treat Diabetes

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes

Insulin switch & Algorithms Rotorua GP CME June Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB

ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST

Diabetes in Primary Care course MCQ Answers 2016

Dr. John Bucheit, Pharm.D., BCACP, CDE Clinical Assistant Professor Mercer University College of Pharmacy

Add: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above

Diabetes Medications: Insulin Therapy

Algorithms for Glycemic Management of Type 2 Diabetes

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2

INSULIN INTENSIFICATION: Taking Care to the Next Level

Type 2 diabetes Definition

Calculating Insulin Dose

Update on the management of Type 2 Diabetes

Approximate Cost Reference List i for Antihyperglycemic Agents

Insulin Initiation and Intensification

Medicines for Type 2 Diabetes A Review of the Research for Adults

There seem to be inconsistencies regarding diabetic management in

Diabetes: Medications

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco

Treatment of Type 2 Diabetes

Initiating & titrating insulin & switching in General Practice Workshop 1

10/30/2012. Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University of South Alabama Mobile, Alabama

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Workshop A Tara Kadis

Intensifying Insulin Therapy

INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?

Diabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Distinguishing between Diabetes Mellitus Type 1 and Type 2, (with Overview of Treatment Strategies)

SHORT CLINICAL GUIDELINE SCOPE

Insulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

The basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Making Clinical Sense of Diabetes Medications. Types of Diabetes. Pathophysiology. Beta Cell Function & Glucagon

Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE

NCT sanofi-aventis HOE901_3507. insulin glargine

Fundamentals of Diabetes Care Module 5, Lesson 1

SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS

A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes


Initiate Atorvastatin 20mg daily

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Diabetes Fundamentals

Antidiabetic Drugs. Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.

Diabetes Medications. Minal Patel, PharmD, BCPS

Diabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute

FYI: (Acceptable range for blood glucose usually mg/dl. know your institutions policy.)

Treating Type 2 Diabetes Mellitus: a New York State Medicaid Clinical Guidance Document

Primary Care Type 2 Diabetes Update

Understanding Diseases and Treatments with Canadian Real-world Evidence

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

CLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies

Guidelines for Type 2 Diabetes Diagnosis

Presented By: Dr. Nadira Husein

Type 2 Diabetes Medicines: What You Need to Know

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Chapter 4 Type 2 Diabetes

Types of insulin and How to Use Them

(30251) Insulin SQ Prandial Carbohydrate

linagliptin, 5mg film-coated tablet (Trajenta ) SMC No. (746/11) Boehringer Ingelheim / Eli Lilly and Company Ltd

Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults

Diabetes in Children and Adolescents

TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS. Friday, August 16, 13

INSULINThere are. T y p e 1 T y p e 2. many different insulins for

DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS

Causes, incidence, and risk factors

A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration

Case Studies: Initiation and Optimization of Insulin Therapy. Martha Nolte Kennedy, MD UCSF March, 2009

Pharmaceutical Management of Diabetes Mellitus

Information for Patients

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

Medications for Diabetes

Diabetes Update Lanita S. Shaverd, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor, UAMS College of Pharmacy

New Pharmacotherapies for Type 2 Diabetes

Type 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

Noninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause hypoglycemia MED GROUP DESCRIPTOR

David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010

Diabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th Presenter: Derek Sanders, D.Ph.

Transcription:

Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than normal and has lost approximately 20 pounds (9.1 kg) in the past 6 months without trying. His random glucose today is 252 mg/dl (14.0 mmol/l). Which of the following is most appropriate to confirm diagnosis of type 2 diabetes? A. Obtain a fasting glucose level in the morning. B. Have patient perform a 2-hour oral glucose tolerance test. C. Obtain patient s hemoglobin A 1c. D. Obtain a repeat random glucose level. E. Nothing; there is enough information available to diagnose patient with type 2 diabetes. 2. A 36-year-old Caucasian woman is concerned about her risks for developing type 2 diabetes because her mother and father have the disease. Currently, she weighs 145 lbs (66 kg; BMI = 22 kg/m 2 ) and has no other medical conditions. All of her children weighed less than 8 lbs (3.6 kg) at birth and she is preparing for her second marathon. The most appropriate recommendation for screening is to begin: A. At the age of 45 then every 3 years if normal. B. At the age of 45 then every year if normal. C. At the age of 40 then every 3 years if normal. D. At the age of 40 then every year if normal. E. As soon as possible then every year if normal. Questions 3 5 refer to the following case: A 67-year-old Caucasian woman has been recently diagnosed with type 2 diabetes. Her past medical history is significant for hypertension, hyperlipidemia, and hypothyroidism. Her current medications include hydrochlorothiazide, levothyroxine, and simvastatin. At diagnosis, her vitals and labs were as follows: BP 157/94 mm Hg, Wt 157 lbs (71 kg; BMI = 24 kg/m 2 ), A 1c 8.7% (0.087; 72 mmol/mol Hgb), FPG 174 mg/dl (9.7 mmol/l), LDL 52 mg/dl (1.34 mmol/l), HDL 59 mg/dl (1.53 mmol/l), TG 45 mg/dl (0.51 mmol/l). 3. Which of the following is the most appropriate recommendation for therapy according to the ADA algorithm? A. Lifestyle changes only B. Metformin only C. Intensive insulin only D. Lifestyle changes and metformin E. Lifestyle changes and intensive insulin

Diabetes Mellitus 2 4. What is the patient s goal blood pressure according to current ADA treatment guidelines? A. Less than 125/80 B. Less than 130/80 C. Less than 135/85 D. Less than 140/90 E.Less than 150/90 5. What is the most appropriate medication to add to the patient s regimen to control her hypertension? A. Amlodipine B. Clonidine C. Lisinopril D. Metoprolol E. Verapamil 6. Which of the following statements regarding nonpharmacologic therapy for treatment of diabetes is true? A. Individualized meal plans should be developed for people with diabetes based on cultural preferences, comorbidities, and daily schedule as much as possible. B. Current clinical evidence supports the use of dietary supplements such as chromium in the management of diabetes. C. Weight loss works best for patients with type 1 diabetes since most are overweight. D. Long-term goals for physical activity should include at least 30 minutes of aerobic exercise once a week for all patients with diabetes. E. Influenza vaccinations are recommended for all patients with diabetes every 5 years. 7. A 12-year-old boy is newly diagnosed with type 1 diabetes. His current height is 60 in (152 cm) and he weighs 40 kg (88 lb). What dose of basal insulin should be initiated for him? A. 12 units insulin glargine B. 6 units insulin lispro C. 4 units insulin detemir D. 3 units insulin aspart E. 2 units insulin glulisine 8. Oral glucose lowering agents that primarily inhibit the breakdown of glucagon-like peptide 1 are classified as: A. Sulfonylureas B. SGLT2 inhibitors C. DPP-4 inhibitors

Diabetes Mellitus 3 D. Meglitinides E. Thiazolidinediones 9. A 32-year-old woman is diagnosed with gestational diabetes after being administered an oral glucose tolerance test during her 28th-week of gestation. She has not been able to reduce or control her glucose readings with lifestyle interventions alone and her physician wants to start pharmacotherapy. Which agent below is the preferred medication, considering her glucose readings are significantly elevated? A. Glyburide B. Insulin glargine C. NPH insulin D. Liraglutide E. Metformin 10. A 59-year-old Asian American woman has a 3-year history of T2DM. She presents with no new complaints today. Her labs and vitals are: A 1c 8.1% (0.081; 65 mmol/mol Hgb), FBG 320 mg/dl (17.8 mmol/l), LDL 118 mg/dl (3.05 mmol/l), HDL 32 mg/dl (0.83 mmol/l), TG 325 mg/dl (3.67 mmol/l), SCr 1.9 mg/dl (168 µmol/l), BP 128/78 mm Hg, HR 68 beats/min, Wt 135 lb (61.4 kg), Ht 5 2 (157 cm). Her current medications are: Glimepiride 2 mg once daily Metformin 1000 mg twice daily Exenatide 10 mcg twice daily Sitagliptin 50 mg daily Alendronate 70 mg/week Simvastatin 20 mg once daily Paroxetine 20 mg once daily Aspirin 81 mg once daily Which of her medications should be discontinued and for what reason? A. Glimepiride may increase risk of heart failure B. Metformin due to renal dysfunction C. Exenatide may cause weight gain D. Sitagliptin may increase nausea and vomiting E. None of her medications should be discontinued 11. A 38-year-old man with type 1 diabetes presents requesting help with his insulin management. He needs to update his insulin to carbohydrate ratio in order to accurately dose his bolus insulin at meals. Which rule below should he use to calculate his insulin to carbohydrate ratio given that he administers insulin lispro in his pump? A. Rule of 450 B. Rule of 500 C. Rule of 1500 D. Rule of 1800

Diabetes Mellitus 4 E. Rule of 2000 12. A 17-year-old female patient with type 1 diabetes currently uses a total of 40 units of insulin aspart daily in her pump. What is the expected reduction in glucose per unit of insulin for her? A. 12.5 mg/dl (0.7 mmol/l) B. 30 mg/dl (1.7 mmol/l) C. 37.5 mg/dl (2.1 mmol/l) D. 45 mg/dl (2.5 mmol/l) E. 50 mg/dl (2.8 mmol/l) 13. Select the oral medication from the list below that is most likely to result in weight loss for patients with diabetes. A. Dapagliflozin B. Glyburide C. Liraglutide D. Pioglitazone E. Sitagliptin 14. A 57-year-old man has had type 2 diabetes for approximately 15 years. His physician is initiating insulin therapy today due to his elevated A 1c despite oral therapy. Which of the following is the most appropriate option? A. Initiate insulin glargine 10 units every night at bedtime B. Initiate insulin lispro 10 units every night at bedtime C. Initiate insulin aspart 10 units every morning D. Initiate insulin glulisine 10 units twice daily E. Initiate 70% insulin aspart protamine/30% insulin aspart 10 units every night at bedtime 15. All of the following are true regarding noninsulin injectable therapy for treatment of diabetes, except: A. Albiglutide is administered once weekly. B. Exenatide lowers glucose levels by several mechanisms including regulating gastric emptying. C. Liraglutide and albiglutide are administered without regard to meals. D. Pramlintide is approved for use in patients with type 1 and 2 diabetes currently using insulin E. Pramlintide is as effective as insulin at lowering A 1C levels in patients with type 1 diabetes.

Diabetes Mellitus 5 Answers 1. E 2. A 3. D 4. D 5. C 6. A 7. A 8. C 9. C 10. B 11. B 12. D 13. A 14. A 15. E